脊髓转移癌的临床研究

doi:10.3760/cma.j.issn.1673-422X.2014.02.014

国际肿瘤学杂志 ›› 2014, Vol. 41 ›› Issue (2): 124-126.doi: 10.3760/cma.j.issn.1673-422X.2014.02.014

脊髓转移癌的临床研究

李瑞健, 于亮

264100 山东省烟台市牟平人民医院肿瘤科

收稿日期:2013-09-16 修回日期:2013-12-20 出版日期:2014-02-08 发布日期:2014-01-26
通讯作者: 于亮，E-mail：yuliang818@126.com E-mail:yuliang818@126.com

Clinical research for intramedullary spinal cord metastases

Li Ruijian, Yu Liang

Department of Oncology, Muping People′s Hospital of Shandong Province Yantai, Yantai 264100, China

Received:2013-09-16 Revised:2013-12-20 Online:2014-02-08 Published:2014-01-26
Contact: Yu Liang E-mail:yuliang818@126.com

摘要/Abstract

摘要： 脊髓转移癌（ISCM）在临床中并不常见，肺癌和乳腺癌是其最常见的原发肿瘤。患者主要表现为虚弱无力、感觉异常或缺失，可以累及任何节段的脊髓。核磁共振成像是目前ISCM最有效的无创检查手段。ISCM的最佳治疗方法尚存争议，目前主要以手术和放疗为主，整体预后较差，确诊后的中位生存时间大约为4～9个月。

关键词: 脊髓肿瘤, 肿瘤转移, 治疗, 临床特征

Abstract: Intramedullary spinal cord metastases (ISCM) is infrequently observed clinically, spreading mainly from lung cancer and breast cancer, and they can occur in any location of the spinal cord, with weakness and sensory alteration or loss presenting in most patients. Magnetic resonance imaging is the most effective and noninvasive technique for diagnosis until now. The optimal treatment for ISCM remains controversial, and surgical excision and radiotherapy are the most common recommendations. Regardless of the treatment, its prognosis is poor now, with the median survival time 4-9 months.

Key words: Spinal cord neoplasms, Neoplasm metastasis, Therapy, Clinical feature

李瑞健, 于亮. 脊髓转移癌的临床研究[J]. 国际肿瘤学杂志, 2014, 41(2): 124-126.

Li Ruijian, Yu Liang. Clinical research for intramedullary spinal cord metastases[J]. Journal of International Oncology, 2014, 41(2): 124-126.

参考文献

［1］ Kalayci M, Caˇgavi F, Gül S, et al. Intramedullary spinal cord metastases: diagnosis and treatment—an illustrated review［J］. Acta Neurochir (Wien), 2004, 146(12): 1347-1354. ［2］ Kalita O. Current insights into surgery for intramedullary spinal cord metastases: a literature review［J］. Int J Surg Oncol, 2011, 2011: 989506. ［3］ Hrabalek L, Kalita O, Studentova H, et al. Intramedullary spinal cord and cauda equina metastasis of breast carcinoma: case report［J］. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2010, 154(2): 175177. ［4］ Sung WS, Sung MJ, Chan JH, et al. Intramedullary spinal cord metastases: a 20year institutional experience with a comprehensive literature review［J］. World Neurosurg, 2013, 79(34): 576584. ［5］ Rostami R, Safarpour D, Tavassoli FA, et al. Intramedullary metastasis in breast cancer—a comprehensive literature review［J］. J Neurol Sci, 2013, 332(12): 1620. ［6］ DamHieu P, Seizeur R, Mineo JF, et al. Retrospective study of 19 patients with intramedullary spinal cord metastasis［J］. Clin Neurol Neurosurg, 2009, 111(1): 1017. ［7］ Lee SS, Kim MK, Sym SJ, et al. Intramedullary spinal cord metastases: a singleinstitution experience［J］. J Neurooncol, 2007, 84(1): 8589. ［8］ Ishii T, Terao T, Komine K, et al. Intramedullary spinal cord metastases of malignant melanoma: an autopsy case report and review of the literature［J］. Clin Neuropathol, 2010, 29(5): 334340. ［9］ Veeravagu A, Lieberson RE, Mener A, et al. CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases［J］. J Clin Neurosci, 2012, 19(9): 12731277. ［10］ Conill C, Marruecos J, Verger E, et al. Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer［J］. Clin Transl Oncol, 2007, 9(3): 172176. ［11］ Hrabalek L. Intramedullary spinal cord metastases: review of the literature［J］. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2010, 154(2): 117122. ［12］ DoDai DD, Brooks MK, Goldkamp A, et al. Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review［J］. Curr Probl Diagn Radiol, 2010, 39(4): 160185. ［13］ Nguyen NC, Sayed MM, Taalab K, et al. Spinal cord metastases from lung cancer: detection with F18 FDG PET/CT［J］. Clin Nucl Med, 2008, 33(5): 356358. ［14］ Gilardi L, Vassallo S, Colandrea M, et al. Intramedullary spinal cord metastases from breast cancer: detection with (18)FFDG PET/CT［J］. Ecancermedicalscience, 2013, 7: 329. ［15］ Hashii H, Mizumoto M, Kanemoto A, et al. Radiotherapy for patients with symptomatic intramedullary spinal cord metastasis［J］. J Radiat Res, 2011, 52(5): 641645. ［16］ Wilson DA, Fusco DJ, Uschold TD, et al. Survival and functional outcome after surgical resection of intramedullary spinal cord metastases［J］. World Neurosurg, 2012, 77(2): 370374. ［17］ Hoover JM, Krauss WE, Lanzino G. Intradural spinal metastases: a surgical series of 15 patients［J］. Acta Neurochir (Wien), 2012, 154(5): 871877. ［18］ Belaid I, Jlassi H, Debbiche G, et al. Lung adenocarcinoma with intramedullary spinal cord metastasis: a case report and review of the literature［J］. Rev Pneumol Clin, 2013, 69(3): 149151. ［19］ Kodama M, Kawaguchi H, Komoto Y, et al. Coexistent intramedullary spinal cord and choroidal metastases in ovarian cancer［J］. J Obstet Gynaecol Res, 2010, 36(1): 199203. ［20］ Choi HC, Yoon do H, Kim SC, et al. Two separate episodes of intramedullary spinal cord metastasis in a single patient with breast cancer［J］. J Korean Neurosurg Soc, 2010, 48(2): 162165.

[1]	钱晓涛, 石子宜, 胡格, 吴晓维. Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[4]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[5]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[6]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟. 铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[7]	王昆, 周中新, 臧其威. 血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[8]	萨蔷, 徐航程, 王佳玉. 乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[9]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙. 肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[10]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛. 铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[11]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛. 索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.
[12]	严爱婷, 王翠竹, 刘春桂, 鲁小敏. 卡瑞利珠单抗与信迪利单抗治疗晚期非小细胞肺癌的临床疗效及安全性分析[J]. 国际肿瘤学杂志, 2024, 51(3): 137-142.
[13]	李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵. 寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174.
[14]	彭琴, 蔡玉婷, 王伟. KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[15]	岳红云, 张百红. 肿瘤的分化治疗[J]. 国际肿瘤学杂志, 2024, 51(2): 109-113.

脊髓转移癌的临床研究

Clinical research for intramedullary spinal cord metastases

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价